查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492500

电脑辅助药物发现市场：按类型、治疗领域和最终用户划分 - 2024-2030 年全球预测

Computer-aided Drug Discovery Market by Type (Ligand-Based Drug Design, Sequence-Based Approaches, Structure-Based Drug Design), Therapeutic Area (Cardiovascular Disease, Diabetes, Neurology), End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年电脑辅助药物发现市场规模预计为37.4亿美元，预计2024年将达到40.8亿美元，2030年将达到71.6亿美元，复合年增长率预计为9.71%。

电脑辅助药物发现 (CADD) 是生物製药行业中用于加速和增强候选药物发现过程的科学技术。 CADD 利用计算方法来模拟和预测药物与生物标的之间的相互作用。此过程允许在实验室合成和测试候选药物之前对其进行识别，从而节省时间和资源。随着临床试验的增加，生物技术和製药行业的成长正在推动对电脑辅助药物发现解决方案的需求。 CADD 透过预测候选药物与其标靶结合或引起副作用的可能性，可以显着缩短药物发现时间。这种效率对于缩短上市时间非常有利的产业至关重要。高昂的初始成本和对品质资料的日益依赖阻碍了市场的成长。运算能力的进步和演算法的改进提高了 CADD 的效率和能力，预计将创造市场成长机会。

主要市场统计
基准年[2023] 37.4亿美元
预测年份 [2024] 40.8亿美元
预测年份 [2030] 71.6亿美元
复合年增长率（%） 9.71%

区域洞察

在美洲，由于对医疗保健技术的大量投资和大型製药公司的存在，电脑辅助药物发现市场高度发展。电脑辅助系统广泛用于加速药物发现、降低成本、提高开发新药效率。此外，由于医疗保健支出的增加和製药业的成长，南美洲国家越来越多地采用这些技术。由于医疗保健技术投资的增加、製药公司和研究机构数量的增加，亚太地区的 Research_KEYWORD 市场正在快速成长。中国和印度等国家由于人口众多且对改善医疗保健的兴趣日益浓厚，正在引领市场。该地区受益于先进技术的引进和政府对医疗保健研究的支持力度的加大。欧洲市场强劲，拥有先进的研究设施和对药物开发的大量投资。欧洲国家在开发支持高效药物发现过程的先进技术方面拥有强大的立足点。中东和非洲部分地区在采用这些技术方面正在取得进展，儘管速度慢于欧洲。这些地区的成长主要是由医疗保健部门私有化程度的提高以及寻求加强医疗保健基础设施的国家对新技术的投资所推动的。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在电脑辅助药物发现市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对电脑辅助药物发现市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在电脑辅助药物发现市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药和生物製药公司对药物开发活动的日益关注
      • 管理临床前研究过程中产生的大量资料的需求日益增长。
    • 抑制因素
      • 实施电脑辅助药物发现解决方案的成本高昂
    • 机会
      • 电脑辅助药物发现解决方案中技术的进一步整合
      • 支持引进创新技术的政府政策
    • 任务
      • 与电脑辅助药物发现解决方案相关的各种替代技术的可用性
  • 市场区隔分析
    • 类型：越来越多地使用基于配体的药物设计来开发可以预测新化合物活性的模型
    • 最终用户：电脑辅助药物发现在了解生物过程和识别潜在新药方面的巨大潜力
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第 6 章电脑辅助药物发现市场：按类型

  • 基于配体的药物设计
  • 基于序列的方法
  • 基于结构的药物设计

第 7 章：按治疗领域分類的电脑辅助药物发现市场

  • 循环系统疾病
  • 糖尿病
  • 神经病学
  • 肿瘤学
  • 呼吸系统疾病

第八章电脑辅助药物发现市场：按最终用户

  • 生技公司
  • 製药公司
  • 研究室

第 9 章美洲电脑辅助药物发现市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章按电脑辅助区域分類的亚太药物发现市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 电脑辅助的欧洲、中东和非洲药物发现市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • MilliporeSigma 宣布推出 AIDDISON：简化药物开发的开创性 SaaS 平台
    • 拜耳公司和 Google Cloud 合作透过量子化学推进新药发现
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5D693B46C018

[195 Pages Report] The Computer-aided Drug Discovery Market size was estimated at USD 3.74 billion in 2023 and expected to reach USD 4.08 billion in 2024, at a CAGR 9.71% to reach USD 7.16 billion by 2030.

Computer-aided drug discovery (CADD) is a scientific technique used in the biopharmaceutical industry to expedite and enhance the process of discovering new drug candidates. CADD utilizes computational approaches to simulate and predict the interaction between drugs and biological targets. This process can help identify potential new drugs before they are synthesized and tested in the lab, saving time and resources. Growth in the biotechnology and pharmaceutical industries with an increasing number of clinical trials is driving the demand for computer-aided drug discovery solutions. CADD can significantly shorten the drug discovery timeline by predicting how likely a drug candidate is to bind to its target and if it might cause side effects. This efficiency is crucial for industries where reducing time to market can be highly beneficial. High initial costs and rising reliance on quality data hamper the market growth. Rising improvements in computational power and algorithms that enhance the efficiency and capabilities of CADD are expected to create opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.74 billion
Estimated Year [2024] USD 4.08 billion
Forecast Year [2030] USD 7.16 billion
CAGR (%) 9.71%

Regional Insights

In the Americas, the computer-aided drug discovery market is highly developed due to significant investments in healthcare technology and the strong presence of pharmaceutical giants. Computer-aided systems are extensively used to speed up drug discovery, reduce costs, and increase efficiency in developing new drugs. There's also a growing trend in South American countries to adopt these technologies, driven by increasing healthcare expenditures and growing pharmaceutical sectors. The APAC region is witnessing rapid growth in the computer-aided drug discovery market fueled by increasing investment in healthcare technology and a rise in pharmaceutical companies and research institutions. Countries including, China and India are leading the way, given their large populations and increasing focus on healthcare improvements. The region benefits from advanced technology adoption and increased governmental support in healthcare research. The market in Europe is robust, with advanced research facilities and substantial investments in drug development. European countries have a strong foothold in developing advanced technologies that aid in efficient drug discovery processes. The Middle East and parts of Africa are progressively adopting these technologies, although slower than Europe. The growth in these regions is primarily driven by increasing health sector privatization and investments in new technologies by countries aiming to bolster their healthcare infrastructures.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Computer-aided Drug Discovery Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising focus on drug development activities by pharmaceutical and biopharmaceutical companies
      • Increasing need to manage the large data generated during preclinical studies
    • Market Restraints
      • High cost of implementation of computer-aided drug discovery solutions
    • Market Opportunities
      • Rising integration of technologies in computer-aided drug discovery solutions
      • Supportive government policies for the adoption of innovative technologies
    • Market Challenges
      • Availability of wide alternative technologies associated with computer-aided drug discovery solutions
  • Market Segmentation Analysis
    • Type: Growing usage of ligand-based drug design to develop a model that can predict the activity of new compounds
    • End User: High potential of computer-aided drug discovery to understand biological processes and identify potential new drugs
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Computer-aided Drug Discovery Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Computer-aided Drug Discovery Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

MilliporeSigma Introduces AIDDISON: A Pioneering SaaS Platform for Streamlined Drug Development

MilliporeSigma has unveiled AIDDISON, the first software-as-a-service (SaaS) platform that integrates virtual molecule design with practical manufacturability. Leveraging the Synthia retrosynthesis software API, AIDDISON employs generative AI and machine learning within a computer-aided drug design framework. The platform effectively accelerates the drug discovery process by sifting through over 60 billion molecular combinations, pinpointing compounds that exhibit crucial drug attributes including, non-toxicity, solubility, and stability. [Published On: 2023-12-05]

Bayer AG and Google Cloud Partner to Advance Drug Discovery Through Quantum Chemistry

Bayer AG and Google Cloud have announced a strategic partnership aimed at enhancing early-stage drug discovery by utilizing Google Cloud's Tensor Processing Units (TPUs). These custom-built accelerators are designed to manage advanced machine-learning models and demanding computational tasks. This collaboration seeks to significantly improve the speed and scalability of quantum chemistry calculations, which are crucial for in-silico modeling that accurately simulate biological and chemical interactions. [Published On: 2023-01-11]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Computer-aided Drug Discovery Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Computer-aided Drug Discovery Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accelrys, Inc., AstraZeneca PLC, Bayer AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim International GmbH, Chemical Computing Group Inc., Dassault Systemes SE, Eli Lilly and Company, Gilead Sciences, Inc., GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc., Roche Holding AG, Sanofi S.A., Schrodinger, Inc., Simulations Plus, Inc., and Vertex Pharmaceuticals Incorporated.

Market Segmentation & Coverage

This research report categorizes the Computer-aided Drug Discovery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Ligand-Based Drug Design
    • Sequence-Based Approaches
    • Structure-Based Drug Design
  • Therapeutic Area
    • Cardiovascular Disease
    • Diabetes
    • Neurology
    • Oncology
    • Respiratory Disease
  • End User
    • Biotechnology Companies
    • Pharmaceutical Companies
    • Research Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising focus on drug development activities by pharmaceutical and biopharmaceutical companies
      • 5.1.1.2. Increasing need to manage the large data generated during preclinical studies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of implementation of computer-aided drug discovery solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising integration of technologies in computer-aided drug discovery solutions
      • 5.1.3.2. Supportive government policies for the adoption of innovative technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of wide alternative technologies associated with computer-aided drug discovery solutions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Growing usage of ligand-based drug design to develop a model that can predict the activity of new compounds
    • 5.2.2. End User: High potential of computer-aided drug discovery to understand biological processes and identify potential new drugs
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Computer-aided Drug Discovery Market, by Type

  • 6.1. Introduction
  • 6.2. Ligand-Based Drug Design
  • 6.3. Sequence-Based Approaches
  • 6.4. Structure-Based Drug Design

7. Computer-aided Drug Discovery Market, by Therapeutic Area

  • 7.1. Introduction
  • 7.2. Cardiovascular Disease
  • 7.3. Diabetes
  • 7.4. Neurology
  • 7.5. Oncology
  • 7.6. Respiratory Disease

8. Computer-aided Drug Discovery Market, by End User

  • 8.1. Introduction
  • 8.2. Biotechnology Companies
  • 8.3. Pharmaceutical Companies
  • 8.4. Research Laboratories

9. Americas Computer-aided Drug Discovery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Computer-aided Drug Discovery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Computer-aided Drug Discovery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. MilliporeSigma Introduces AIDDISON: A Pioneering SaaS Platform for Streamlined Drug Development
    • 12.3.2. Bayer AG and Google Cloud Partner to Advance Drug Discovery Through Quantum Chemistry
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. COMPUTER-AIDED DRUG DISCOVERY MARKET RESEARCH PROCESS
  • FIGURE 2. COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. COMPUTER-AIDED DRUG DISCOVERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. COMPUTER-AIDED DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. COMPUTER-AIDED DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPUTER-AIDED DRUG DISCOVERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND-BASED DRUG DESIGN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY LIGAND-BASED DRUG DESIGN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE-BASED APPROACHES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY SEQUENCE-BASED APPROACHES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE-BASED DRUG DESIGN, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STRUCTURE-BASED DRUG DESIGN, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESPIRATORY DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESPIRATORY DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM COMPUTER-AIDED DRUG DISCOVERY MARKET SIZE, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 289. COMPUTER-AIDED DRUG DISCOVERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 290. COMPUTER-AIDED DRUG DISCOVERY MARKET, FPNV POSITIONING MATRIX, 2023